Table of Contents
What changed
Revenue fell 19.6% to $385.4m and EBITDA swung from $31.4m to –$2.5m, carrying PBT from $3.8m to –$33.1m and NPAT from $2.6m to –$24.4m. Operating cash flow dropped 75.3% to $10.4m despite lower capex of $6.9m, leaving pre-lease free cash flow of just $3.6m versus $32.7m a year ago. The balance sheet moved decisively: cash rose modestly to $13.7m, but the group drew $50.0m of new borrowings (nil prior), flipping from net cash of $8.7m to net debt of $36.3m and taking total liabilities up 41.5% while equity fell 8.0% to $182.3m. No dividend was declared in the current announcement, against $0.02 per share in FY24. Segment disclosure shifted from Distribution/Infrastructure to Distribution/Processing/Others; Distribution (~59% of revenue) ran at roughly –6.8% EBIT margin and Processing at roughly –7.7%, with only the small Others segment profitable.
What matters
- Earnings quality has deteriorated across the stack, not just at the headline. EBITDA is negative, PBT is –$33.1m, and the NPAT tax shield of roughly $8.7m flatters the bottom line — PBT growth of –971% is the cleaner operating read. There are no disclosed non-recurring items to strip out, so the loss should be read as core.
- Leverage direction, not absolute level, is the key balance-sheet signal. A $45.0m swing into net debt while operating cash generation collapsed means the new $50.0m drawdown is effectively funding working capital and the loss, not growth capex (capex actually fell to $6.9m from $9.5m).
- The stated strategy of "strengthening the core while investing in high value products" is not yet visible in segment economics. Both core segments are loss-making in FY25 and the ~$7m annualised cost-out programme is small relative to a $33.9m EBITDA reversal.
Expectations
No quantified revenue or earnings target was supplied. Management flags "some activity lift in 2H25" and expected improvement through FY26, but the implied 2H25 shape is weaker than the first half on the key lines: implied 2H25 EBITDA of –$3.1m (versus +$0.6m in HY25) and implied 2H25 NPAT of –$14.0m (versus –$10.4m in HY25). Operating cash flow is where the second-half weakness is starkest — HY25 delivered $23.1m but full-year OCF was only $10.4m, implying 2H25 operating cash of roughly –$12.7m. On the evidence supplied, the release does not support a visible inflection inside FY25; any FY26 recovery case has to rest on market conditions plus the cost-out programme rather than on second-half run-rate.
Quality of result
The result looks core-driven rather than one-off. There is no disclosed discontinued operation, disposal loss, or non-recurring adjustment explaining the PBT-to-NPAT gap; the divergence is simply a tax credit on the loss (implied effective tax rate ~26%). Cash conversion deteriorated materially: OCF-to-EBITDA flipped from 134% to –417% (on a small negative EBITDA) and receivable days extended from 41.8 to 52.1 while inventory days rose from 92.4 to 107.6, despite the inventory dollar balance falling 6.4%. Those working-capital days are volume-denominator effects as much as discipline lapses, but they confirm the cash result is not being helped by working-capital release. The modestly positive $3.6m pre-lease FCF is a function of cutting capex, not operating strength.
Unresolved
- What share of the FY25 loss is structural versus cyclical, given both core segments are loss-making and the cost-out programme is only ~$7m annualised?
- What are the covenants, pricing and maturity on the new $50.0m of borrowings, and how much headroom remains in the previously cited $100m facility?
- Why was the segmentation rebased from Distribution/Infrastructure to Distribution/Processing/Others, and what does like-for-like Distribution look like on the old basis?
- With no dividend in the current announcement, is the board signalling a suspension or simply deferral, and what is the policy linkage to FCF or leverage?
- This briefing cannot assess forward earnings trajectory, covenant risk, or valuation, because no quantified guidance, debt terms, or NTA/per-share asset data were supplied.
Key metrics
| Metric | FY25 | FY24 | Change |
|---|---|---|---|
| Revenue | $385.4m | $479.1m | -19.6% ↓ |
| EBITDA | −$2.5m | $31.4m | -108.0% ↓ |
| Net profit after tax | −$24.4m | $2.6m | -1023.1% ↓ |
| Net cash inflow from operating activities | $10.4m | $42.2m | -75.3% ↓ |
| Declared dividend per share | — | 2.0c | — |
| Operating profit | −$26.0m | $9.6m | -371.2% ↓ |
| Profit before tax | −$33.1m | $3.8m | -971.3% ↓ |
| Cash and cash equivalents | $13.7m | $8.7m | +57.9% ↑ |
| Total assets | $402.6m | $353.8m | +13.8% ↑ |
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| Distribution | $228.9m | $276.9m | −$15.6m | +1.6pp |
| Processing | $151.1m | — | −$11.7m | n/a |
| Others | $5.4m | — | $1.3m | n/a |
Analytical metrics
| Metric | FY25 | FY24 | Context |
|---|---|---|---|
| Effective tax rate | n/m (loss period) | 30.5% | current loss period |
| OCF / EBITDA (cash conversion) | -417.1% | 134.4% | deteriorated |
| FCF pre-lease | $3.6m | $32.7m | −$29.2m |
| FCF / NPAT | -14.6% | n/m | complementary conversion metric |
| Capex % revenue | 1.8% | 2.0% | — |
| Capex | −$6.9m | −$9.5m | +$2.6m |
| Debtor days | 52.1 | 41.8 | +10.4 days |
| Inventory days | 107.6 | 92.4 | +15.2 days |
| Trade debtors | $55.0m | $54.8m | +$0.3m |
| Net debt | $36.3m | −$8.7m | +$45.0m |
| Net debt / EBITDA | -14.51x | -0.28x | Weakening |
| Gross borrowings | $50.0m | $0.0m | +$50.0m |
| ROE (annualised) | -13.4% | 1.3% | Weakening |
| HY25 share of FY25 revenue | 50.9% | — | Other half was 49.1% |
| HY25 share of FY25 EBITDA | -24.0% | — | Other half was 124.0% |
| HY25 share of FY25 NPAT | 42.7% | — | Other half was 57.3% |
| Profit from continuing operations | — | $2.6m | — |
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.